IQVIA Holdings Inc. (IQV) Stock Analysis — Fair Value, Risk & Moat Rating
NYQ · Healthcare · Diagnostics & Research
Is IQVIA Holdings Inc. a safe investment right now?
IQVIA Holdings Inc.'s Altman Z-Score of 1.83 places it in the gray zone. Our fair value estimate is $185.82 (Watch Zone). Moat rating: 3.0/5 stars.
Could IQVIA Holdings Inc. go bankrupt? Altman Z-Score analysis
Z-Score of 1.83 places the company in the gray zone (1.8-3.0), warranting closer scrutiny.
- Below 1.8 — Distress Zone (high bankruptcy risk)
- 1.8 to 3.0 — Gray Zone (elevated uncertainty)
- Above 3.0 — Safe Zone (financially healthy)
What drives IQV's Z-Score?
| Component | Formula | Value | Weight | Contribution |
|---|---|---|---|---|
| A · Working Capital / Total Assets | WC / TA | -0.0698 | 1.2 | -0.08 |
| B · Retained Earnings / Total Assets | RE / TA | 0.248 | 1.4 | 0.35 |
| C · EBIT / Total Assets | EBIT / TA | 0.0775 | 3.3 | 0.26 |
| D · Market Cap / Total Liabilities | MCap / TL | 1.2753 | 0.6 | 0.77 |
| E · Revenue / Total Assets | Rev / TA | 0.5447 | 1.0 | 0.54 |
How has IQV's financial health changed over time?
| Year | Z-Score | Zone |
|---|---|---|
| 2022 | 1.87 | Gray |
| 2023 | 1.9 | Gray |
| 2024 | 1.98 | Gray |
| 2025 | 1.83 | Gray |
Source: Calculated from IQV's latest 10-K filing on SEC EDGAR.
What is IQVIA Holdings Inc. actually worth?
How we calculated this
| Input | Value | Source |
|---|---|---|
| Predicted EPS (α) | $9.78 | Proprietary blend of reported actuals + analyst consensus, weighted by α |
| Last Year EPS | $7.84 | Annual report (SEC EDGAR) |
| Analyst Consensus EPS (This Year) | $12.70 | 20 analysts consensus |
| Trailing P/E | 22.4x | Current market pricing |
| Fair P/E (β discount) | 19.0x | Trailing PE adjusted by value discount factor β, hard-capped |
| Earnings Trend (γ) | Accelerating | Directional signal: predicted vs trailing EPS |
Wall Street Reference: Analyst consensus target price is $231.60 (20 analysts). This is shown for reference only and is not used in our valuation model.
Source: Earnings data from SEC EDGAR filings. Market data via Yahoo Finance.
Does IQVIA Holdings Inc. have a durable competitive advantage?
Moat rating: 3.0/5.
What makes up IQV's moat score?
ROIC Stability
ROIC variability over the past decade. Score: 3/5.
Gross Margin Trend
Gross margin trajectory over the past decade. Score: 3/5.
Switching Costs
Estimated customer lock-in based on margin level. Score: 3/5.
How stable is IQV's return on invested capital?
| Year | ROIC | Trend |
|---|---|---|
| 2022 | 9.6% | — |
| 2023 | 10.8% | Rising |
| 2024 | 11.7% | Stable |
| 2025 | 10.4% | Declining |
Source: ROIC calculated from SEC EDGAR filings.
Is IQVIA Holdings Inc.'s dividend safe?
IQVIA Holdings Inc.'s key financial metrics
| Metric | Latest | 1Y Ago | 3Y Ago | Trend |
|---|---|---|---|---|
| Revenue | $16.3B | $15.4B | $14.4B | Rising |
| Net Income | $1.4B | $1.4B | $1.1B | Rising |
| Free Cash Flow | $2.1B | $2.1B | $1.6B | Rising |
| Gross Margin | 33.3% | 34.9% | 34.9% | Stable |
Recent events that affect our IQV analysis
IQV earnings report scheduled
Upcoming report. Consensus EPS estimate: $2.82. Revenue estimate: $4.10B. Our current Fair Value: $185.82 — a significant beat or miss could shift this estimate.
IQV analyst consensus: 91% bullish (21 of 23 analysts)
4 Strong Buy, 17 Buy, 2 Hold, 0 Sell, 0 Strong Sell. Consensus target: $231.60 (32.2% upside). Compare with our independent Fair Value: $185.82.
IQV filed annual report (10-K)
Annual filing with full-year financials. Our Altman Z-Score, Moat, and Fair Value models are derived from this data. View on SEC EDGAR →
IQV beat EPS estimates by 0.7%
Reported EPS: $3.42 vs estimate $3.40. Earnings strength supports our Fair Value of $185.82 (6.1% above current price).
IQV filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
IQV filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
IQV filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
IQV beat EPS estimates by 0.8%
Reported EPS: $3.00 vs estimate $2.98. Earnings strength supports our Fair Value of $185.82 (6.1% above current price).
IQV filed quarterly report (10-Q)
Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →
IQV filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
IQV filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
IQV missed EPS estimates by 10.9%
Reported EPS: $1.54 vs estimate $1.73. Our Fair Value of $185.82 may face downward pressure if the trend continues.
IQV filed quarterly report (10-Q)
Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →
IQV filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
IQV filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
IQV filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
IQV beat EPS estimates by 2.6%
Reported EPS: $2.70 vs estimate $2.63. Earnings strength supports our Fair Value of $185.82 (6.1% above current price).
IQV filed quarterly report (10-Q)
Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →
IQV filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
IQV filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
IQV filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
IQV filed annual report (10-K)
Annual filing with full-year financials. Our Altman Z-Score, Moat, and Fair Value models are derived from this data. View on SEC EDGAR →
IQV beat EPS estimates by 0.4%
Reported EPS: $3.12 vs estimate $3.11. Earnings strength supports our Fair Value of $185.82 (6.1% above current price).
IQV filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
Common questions about IQVIA Holdings Inc.
What is IQVIA Holdings Inc. stock price today?
IQVIA Holdings Inc. (IQV) stock price is $175.21 as of the latest market close, traded on the NYSE exchange.
What does IQVIA Holdings Inc. do?
IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.
What is IQVIA Holdings Inc. market cap?
IQVIA Holdings Inc. has a market capitalization of $29.73B, classifying it as a large-cap stock in the Healthcare sector.
What sector and industry is IQV in?
IQVIA Holdings Inc. operates in the Healthcare sector, specifically within the Diagnostics & Research industry. It trades on the NYSE under the ticker symbol IQV.
Is IQV stock overvalued or undervalued?
Based on our valuation model, IQVIA Holdings Inc. trades 5.7% below our fair value estimate — potentially undervalued.
- FairValueLabs Fair Value: $185.82
- Current Price: $175.21
- Valuation Zone: Watch Zone
What is IQV stock forecast and analyst target price?
Based on 20 Wall Street analysts, the consensus price target for IQVIA Holdings Inc. is $231.60, implying upside of 32.2% from the current price.
- Analyst High Target: $287.00
- Analyst Low Target: $185.00
Note: Analyst targets are shown for reference and are not used in our valuation model.
Is IQVIA Holdings Inc. revenue and earnings growing?
Here are the analyst consensus growth estimates for IQVIA Holdings Inc.:
- Revenue growth (current year est.): 5.7%
- EPS growth (current year est.): 6.6%
- Revenue growth (next year est.): 5.8%
- EPS growth (next year est.): 10.8%
What are IQVIA Holdings Inc.'s key financial metrics?
| Metric | Latest | Trend |
|---|---|---|
| Revenue | $16.3B | Rising |
| Net Income | $1.4B | Rising |
| Free Cash Flow | $2.1B | Rising |
| Gross Margin | 33.3% | Stable |
What is IQV's P/E ratio?
The price-to-earnings ratio measures how much investors pay per dollar of earnings:
- Trailing P/E (last 12 months): 22.4x
- Forward P/E (next 12 months est.): 12.4x
- FairValueLabs Fair P/E: 19.0x
How volatile is IQV stock?
IQVIA Holdings Inc. has a beta of 1.39, meaning it is somewhat more volatile than the broader market. A beta above 1.0 indicates higher price swings relative to the S&P 500, while below 1.0 suggests more stability.
How much cash and debt does IQVIA Holdings Inc. have?
IQVIA Holdings Inc.'s balance sheet shows:
- Total Cash: $2.14B
- Total Debt: $16.31B
- Net Cash Position: $-14.16B
A positive net cash position means the company holds more cash than debt, reducing financial risk.
What is IQVIA Holdings Inc.'s free cash flow?
IQVIA Holdings Inc. generated $2.22B in trailing twelve-month free cash flow (from $2.65B in operating cash flow). Free cash flow represents the cash available for dividends, buybacks, and debt reduction after all capital expenditures.
Does IQVIA Holdings Inc. pay a dividend?
IQVIA Holdings Inc. does not currently pay a regular dividend to shareholders. The company may be reinvesting all profits back into growth, or it may have suspended its dividend.
Is IQVIA Holdings Inc. at risk of going bankrupt?
IQVIA Holdings Inc.'s Altman Z-Score is 1.83, placing it in the gray zone (1.8–3.0) — some financial uncertainty. The Z-Score uses five balance sheet ratios to predict bankruptcy probability within two years.
Does IQVIA Holdings Inc. have a durable competitive advantage?
IQVIA Holdings Inc. scores 3.0/5 stars (Narrow moat) in our moat analysis:
- ROIC Stability: 3/5
- Gross Margin Trend: 3/5
- Switching Costs: 3/5
A score above 3.5 suggests meaningful pricing power and a defensible market position.
What is IQV's return on equity (ROE)?
IQVIA Holdings Inc.'s return on equity is 21.4%. ROE measures how efficiently a company generates profits from shareholder equity. An ROE above 15% is generally considered strong, while below 10% may signal inefficiency.
How do I buy IQV stock?
IQV shares can be purchased through any brokerage account that provides access to the NYSE. Common steps:
- Open an account with a broker (e.g., Fidelity, Schwab, Interactive Brokers)
- Search for ticker symbol IQV
- Place a market or limit order for your desired number of shares
This is not investment advice. Always do your own research before buying any stock.
Is IQV a value stock or speculative?
FairValueLabs classifies IQVIA Holdings Inc. as Value Investment. It exhibits consistent profitability, reasonable valuation, and financial stability — characteristics of a traditional value investment.
Who is the CEO of IQVIA Holdings Inc.?
The current CEO of IQVIA Holdings Inc. is Mr. Ari Bousbib.
What is IQV's earnings per share (EPS)?
Earnings per share measures the company's profit allocated to each outstanding share:
- Trailing EPS (last 12 months): $7.83
- Forward EPS (next 12 months est.): $14.08
- Analyst consensus EPS (this year): $12.70
- Analyst consensus EPS (next year): $14.08
Other Healthcare companies analyzed by FairValueLabs
FairValueLabs Disclaimer
All valuations, scores, ratings, and classifications on this page are produced by the FairValueLabs internal valuation system. They do not represent actual market value, guaranteed outcomes, or professional investment advice. These are analytical estimates for educational and research purposes only.
This is not financial advice. All data is sourced from SEC EDGAR public filings. Always consult a qualified financial advisor before making investment decisions.
Last updated: Apr 22, 2026. Data sources: SEC EDGAR (financial statements), Yahoo Finance (market data, analyst consensus). Data may not reflect the most recent quarter.
IQV analysis methodology: How we calculate fair value, Z-Scores, and moat ratings